TI
GSK icon

TrueMark Investments’s GSK GSK Stock Holding History

TrueMark Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.36M Buy
115,322
+14,190
+14% +$769K 1.24% 35
2025
Q4 		$4.96M Buy
101,132
+13,158
+15% +$614K 0.95% 39
2025
Q3 		$3.8M Buy
87,974
+4,832
+6% +$189K 0.66% 61
2025
Q2 		$3.19M Buy
83,142
+12,880
+18% +$492K 0.69% 60
2025
Q1 		$2.72M Buy
+70,262
New +$2.57M 0.71% 48

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TrueMark Investments's GSK Position: Q1 2026 in Review

TrueMark Investments increased its GSK (GSK) stake by 14% in Q1 2026, buying an estimated $769K and bringing the position to 115,322 shares worth $6.36M. The position accounts for 1.24% of the portfolio, ranked #35.

TrueMark Investments first reported a position in GSK in Q1 2025 and has held it in 5 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • TrueMark Investments held 115,322 shares of GSK worth $6.36M as of Q1 2026.
  • TrueMark Investments bought 14,190 GSK shares in Q1 2026, an estimated $769K.
  • GSK made up 1.24% of TrueMark Investments's portfolio in Q1 2026, its #35 holding.
  • TrueMark Investments first reported a position in GSK in Q1 2025 and has held it in 5 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on TrueMark Investments's 13F filing for Q1 2026, filed 20 Apr 2026.